Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00966667 · ClinicalTrials.gov registry record

Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer

A clinical trial of Colorectal Cancer, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
222
Enrollment target
14
Study locations

NCT00966667 is a study of Colorectal Cancer that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 222 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (85% lower). The trial reports 14 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00966667, a study of Colorectal Cancer, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
222 participants
Enrollment target
14
Study locations

Study Summary

RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet. PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.

Conditions Studied

Colorectal Cancer

Study Locations (14)

New Jersey

  • Cooper Hospital/University Medical Center - Camden
  • JFK Medical Center in Edison - Edison
  • Centrastate Healthcare System - Freehold
  • Robert Wood Johnson University Hospital at Hamilton - Hamilton
  • Mountainside Hospital - Montclair
  • Morristown Medical Center - Morristown
  • Jersey Shore University Medical Center - Neptune City
  • Rutgers Cancer Institute of New Jersey - New Brunswick
  • Saint Peters University Hospital - New Brunswick
  • University Medical Center at Princeton - Princeton
  • Robert Wood Johnson University Hospital Somerset - Somerville
  • Overlook Medical Center - Summit

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 222 participants
Start Date 2009-11
Est. Completion 2019-08-07

Sponsor

Rutgers, The State University of New Jersey

413 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00966667

The ClinicalTrials.gov registry entry for NCT00966667 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00966667 reports 14 study locations spanning 3 distinct geographic areas - top geographies include New Jersey, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT00966667 about?

NCT00966667 is a clinical study titled "Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer". RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet. PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment...

What is the current status of trial NCT00966667?

This trial is currently completed. The enrollment target is 222 participants. The study started on 2009-11. Estimated completion is 2019-08-07.

What conditions does trial NCT00966667 study?

This clinical trial studies the following conditions: Colorectal Cancer.

Who is sponsoring clinical trial NCT00966667?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00966667 being conducted?

This trial has 14 study locations across New Jersey, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Colorectal Cancer

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.